Board of Directors 

The Board of Directors is the legally and financially responsible body that sets the strategic direction of TOPRA and makes sure that all is running smoothly. Board elections are held annually for Officers and every two years for Directors. Any member, wherever they live or whatever their regulatory experience, can stand for election.

TOPRA's president for 2025, Aman Khera, lays out her plans for presidency in the video below.

The members of the Board in 2025 are:

Office	Term	Name	Career summary
President	1 year	Aman Khera FTOPRA	Aman is Vice President, Regulatory Science, Strategy & Innovation at Worldwide Clinical Trials, a global contract research organisation (CRO). Aman provides global strategic direction in regulatory affairs, having led a wide range of regulatory projects providing strategy and development services for a variety of client sponsor companies.
President-Elect	1 year	Steve Hayes FTOPRA	Steve is MHRA's Regulatory Science Specialist; and is a seasoned regulatory development professional with over 35 years' breadth of experience gained across the company, consulting, public service and government sectors. He has been a TOPRA member since 1990 and became a Fellow in 2016. He has also served previously as President in 2020.
Past-President	1 year	Michael Kipping MTOPRA	Michael is Director of Strategic Partnerships for Element Materials Testing, which is a global testing, inspection, calibration and certification business. Previously, he worked for Innovate UK as a Health Innovation Lead managing a UK government grant funding programme (Biomedical Catalyst) that provided £30M per annum to support UK SMEs developing innovative health and life science products.

Directors

Office	Term	Name and professional position	Career summary
Director	2 years	Harriet Edwards FTOPRA	Harriet is Director of Regulatory Affairs at Boyds. She has been an active member of TOPRA over the last decade. During this time she has sat on the Editorial Board for Regulatory Rapporteur, and been a CSci assessor. She has also been a winner of the Communication Award at the TOPRA Awards for Regulatory Excellence in 2021 and was awarded Fellowship in 2024.
Director	2 years	Eva Kopecna FTOPRA	Eva works for Acino International as Global Head of Regulatory Affairs, Medical and Pharmacovigilance. She has over 35 years combined experience of healthcare and pharmaceutical industry in a range of positions. After spending 12 years as a medical doctor, Eva moved to research and development, and later regulatory affairs where she has built and lead different teams.
Director	2 years	Steve Lee FTOPRA	Steve joined ABHI as Director of Diagnostics Regulation in 2020. After completing his degree in Biochemistry and Biology at Aston University, Steve trained as a Biomedical Scientist, working in hospital microbiology before moving to industry to work as company microbiologist. In 2019, Steve was presented with the TOPRA Award for Regulatory Excellence for Contribution.
Director	2 years	Sonja Morjaria MTOPRA	Sonja has over 15 years’ experience in regulatory affairs and is currently the Associate Director of Regulatory Strategy UK&IE at Vertex Pharmaceuticals. Sonja leads the development of strategies for assets early in the pipeline, through to post marketing for cell and gene therapy products. She has been a TOPRA member since the start of her career and completed her MSc through TOPRA’s programme.
Director	2 years	Sean Russell MTOPRA	Sean is an experienced regulatory leader with over 15 years’ regulatory experience and working knowledge across a vast cross-section of human pharmaceutical regulatory affairs. He currently holds 3 leadership positions in regulatory affairs concurrently: SVP Regulatory Affairs for UK cell therapy biotech, Achilles Therapeutics; Head of Regulatory Affairs for Italian rare disease charity, Fondazione Telethon; and Managing Partner of the consulting firm, PrimeRA Pharma Partners.
Director	2 years	Alex Yates FTOPRA	Alex has been working in Regulatory Affairs since 2002, and is currently Vice President Regulatory Affairs at BicycleTx Ltd (Bicycle). Alex is responsible for the development and execution of the global regulatory strategy for the company’s portfolio. He is also responsible for the development of the global regulatory team, associated supporting systems and infrastructure.